Thanks to high-throughput sequencing technologies, shotgun metagenomic methods were made possible and had effectively transformed microbiology. Today, advances in both short- and long-read ...

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD ...

SHENZHEN, China, Sept. 9, 2019 /PRNewswire/ -- Today the ultra-high-throughput genetic sequencer DNBSEQ-T7, independently developed by MGI Tech Co., Ltd. (MGI), was officially delivered to business ...

Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing shipments of DNBSEQ-T7+ high-throughput sequencing platform at the 2026 ...

Being one of the sequencers with the highest speed among mid-low throughput, DNBSEQ-G99 is advanced depending on MGI’s core DNBSEQ sequencing technology, backed by innovations in biochemistry, ...

The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven ...

Rade Drmanac capped off the 2020 AGBT by unveiling a new instrument and antibody-based chemistry that, for some users, can yield a $100 human genome sequence. February 26, 2020 Marco Island, FL—The ...

The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The ...

Genome sequencing has proven vital for disease monitoring and prevention. But it’s expensive for many organizations. The DNBSEQ-T20x2 is a genome sequencing tool for clinical and research uses that ...